A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients

Study Identifier
P15-760
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Immune & Inflammatory - Other
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    19 - 99 Years

    Protocol Summary

    This study evaluates the safety profile and effectiveness of adalimumab in Korean intestinal Behcet's disease (BD) patients in routine clinical practice.

    Study Locations

    Location
    Status
    Location
    Kyungpook National Univ Hosp /ID# 147937
    Daegu, Daegu Gwang Yeogsi, Republic of Korea, 41944
    Status
    Not applicable
    Location
    Ajou University Hospital /ID# 147938
    Suwon, Gyeonggido, Republic of Korea, 16499
    Status
    Not applicable
    Location
    Pusan Nat Univ Yangsan Hosp /ID# 169243
    Yangsan, Gyeongsangnam-do, Republic of Korea, 50612
    Status
    Not applicable
    Location
    Yonsei University Health System, Severance Hospital /ID# 147932
    Seodaemun-gu, Seoul Teugbyeolsi, Republic of Korea, 03722
    Status
    Not applicable
    Location
    Samsung Medical Center /ID# 147934
    Seoul, Seoul Teugbyeolsi, Republic of Korea, 06351
    Status
    Not applicable
    Location
    Cath Univ Seoul St Mary's Hosp /ID# 147936
    Seoul, Seoul Teugbyeolsi, Republic of Korea, 06591
    Status
    Not applicable
    Showing {first} - {last} of {total} Results